Related Experiment Video
Updated: Oct 11, 2025

09:51
Laparoscopic Anterior Right Hepatectomy: A Single-Center Experience
Published on: December 4, 2023
1.3K
Pure Laparoscopic Versus Open Approach for Living Donor Right Hepatectomy: A Systematic Review and Meta-Analysis.
Yufu Peng1, Bo Li1, Hongwei Xu1
1Department of Liver Surgery, Center of Liver Transplantation, West China Hospital of Sichuan University, Chengdu, China.
Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A
|November 29, 2021
Summary
Pure laparoscopic liver donor right hepatectomy (LLDRH) is safe and effective, offering better donor outcomes than open surgery. This minimally invasive approach leads to lower overall morbidity and shorter hospital stays for living donors.
Area of Science:
- Hepatobiliary Surgery
- Minimally Invasive Surgery
- Transplantation Surgery
Background:
- Pure laparoscopic liver donor right hepatectomy (LLDRH) is a complex procedure with unclear benefits compared to open surgery.
- Assessing the safety and efficacy of LLDRH is crucial for donor selection and surgical practice.
Purpose of the Study:
- To provide comprehensive evidence on the safety and efficacy of LLDRH compared to open liver donor right hepatectomy (OLDRH).
Main Methods:
- A systematic meta-analysis was conducted, searching MEDLINE, Embase, Web of Science, and Cochrane Library databases up to July 2021.
- Data from 6 studies involving 1940 patients were analyzed using fixed-effects or random-effects models.
Main Results:
- LLDRH showed a longer operative time but resulted in lower overall donor morbidity, fewer pulmonary complications, and shorter hospital stays compared to OLDRH.
- Major complications, including biliary issues, portal vein problems, and bleeding, were comparable between LLDRH and OLDRH.
- Recipient outcomes, such as rates of biliary problems, vascular complications, and postoperative liver failure, were similar for both surgical approaches.
Conclusions:
- LLDRH is a safe and effective procedure for living liver donors.
- LLDRH offers superior perioperative outcomes for donors compared to OLDRH, including reduced morbidity and shorter recovery times.

